Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Specimen Handling 74 Magnetic Resonance Spectroscopy 73 Cyclophosphamide 69 pembrolizumab 57 Nivolumab 49 Radiotherapy 48 fludarabine 41 Cisplatin 39 Standard of Care 34 Carboplatin 33 Biopsy 33 Bevacizumab 29 Dexamethasone 28 Rituximab 25 Radiation 25 Temozolomide 24 Surveys and Questionnaires 24 Radiosurgery 24 Practice Guidelines as Topic 24 Gemcitabine 24 Doxorubicin 24 Blood Specimen Collection 24 venetoclax 23 Cytarabine 23 fludarabine phosphate 22 Paclitaxel 21 atezolizumab 20 Ipilimumab 20 Interviews as Topic 19 Fluorouracil 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Simvastatin × 30 days × Clear all

NCT07625930 2026-06-04

RESTAGE

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡